COSCIENS Biopharma (CSCI.TO) Stock Price
COSCIENS Biopharma Price
Revenue at COSCIENS Biopharma has contracted by 8.3% per year over the past 19 years to 7.50 M USD. COSCIENS Biopharma's net margin stands at -138.1%, up from -158.5% several years earlier.
COSCIENS Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
COSCIENS Biopharma business model & stock analysis
Frequently asked questions about COSCIENS Biopharma
7 analysts currently rate the COSCIENS Biopharma stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the COSCIENS Biopharma share trades at 5.50 EUR (6.15 USD).
The COSCIENS Biopharma share (CSCI.TO) is listed on 3 stock exchanges, including: NASDAQ (AEZS), London (0UGB.L), Frankfurt (ET82.F).
The revenue cannot currently be calculated for COSCIENS Biopharma.
The profit cannot currently be calculated for COSCIENS Biopharma.
The P/E ratio cannot be calculated for COSCIENS Biopharma at the moment.
The P/S cannot be calculated for COSCIENS Biopharma currently.
The Eulerpool Quality Score for COSCIENS Biopharma is 3/10.
The ISIN of COSCIENS Biopharma is CA22112H1010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of COSCIENS Biopharma is A1439Z. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of COSCIENS Biopharma is CSCI.TO. The ticker symbol is used to trade COSCIENS Biopharma shares on the stock exchange.
COSCIENS Biopharma stock
COSCIENS Biopharma Peer Group
COSCIENS Biopharma Ticker
All fundamentals and in-depth analysis of COSCIENS Biopharma
Our stock analysis for COSCIENS Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of COSCIENS Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.